Modulating the DNA Damage Response to Improve Treatment Response in Cervical Cancer

Area of Science:

• Oncology
• Molecular Biology
• Virology

Background:

• Cervical cancer is a leading cause of cancer death in women globally.
• Current treatments involve chemoradiation, which causes DNA damage and triggers programmed cell death via the DNA damage response (DDR).
• Human papillomavirus (HPV) is uniquely associated with cervical cancers and significantly impacts the DDR.

Purpose of the Study:

• To review emerging therapeutic strategies for cervical cancer.
• To explore how these strategies modulate the DDR.
• To enhance tumor sensitivity to DNA-damaging agents in HPV-associated cervical cancers.

Main Methods:

• Literature review of current and developing therapeutic strategies.
• Analysis of the role of HPV in modulating the DDR.
• Examination of how DDR-targeting agents can sensitize cervical tumors.

Main Results:

• The DDR pathway is a critical target for novel cervical cancer therapies.
• HPV's interaction with the DDR presents unique opportunities for treatment modulation.
• Developing agents can sensitize HPV-driven cervical tumors to DNA-damaging treatments.

Conclusions:

• Modulating the DDR offers promising new avenues for cervical cancer treatment.
• Targeting the interplay between HPV and DDR can improve therapeutic efficacy.
• Further research into DDR-modulating agents is essential for advancing cervical cancer care.